MYLAN 2264 MYLAN 2264 (Terazosin 2 mg)

This pill with imprint "MYLAN 2264 MYLAN 2264" is Black / Purple, Capsule-shape and has been identified as Terazosin hydrochloride 2 mg. It is manufactured by Mylan Pharmaceuticals Inc..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 2 mg is not a controlled substance under the Controlled Substance Act (CSA).

Terazosin hydrochloride

Imprint:

MYLAN 2264 MYLAN 2264

Strength:

2 mg

Color:

Black / Purple

Size:

14.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Antiadrenergic agents, peripherally acting

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-2264

Inactive Ingredients:

lactose anhydrous
silicon dioxide
D&C Red No. 28
D&C Red No. 33
FD&C Blue No. 1
gelatin
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
titanium dioxide
ferrosoferric oxide
ammonia
propylene glycol
dimethicone
shellac

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0937	UDL Laboratories Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.